Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL3334601 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| Propionic Acid SCHEMBL430847 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| Propionic Acid SCHEMBL430848 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL20562036 | 0.95 | FAAH (0.55) | FAAHKMT2AMEN1SLC6A5 | |
| SCHEMBL14958006 | 0.95 | FAAH (0.55) | FAAHKMT2AMEN1SLC6A5 | |
| SCHEMBL75308 | 0.95 | FAAH (0.55) | FAAHKMT2AMEN1SLC6A5 | |
| SCHEMBL75307 | 0.95 | FAAH (0.55) | FAAHKMT2AMEN1SLC6A5 | |
| Glycolic Acid SCHEMBL432567 | 0.94 | FAAH (0.52) | FAAHTERTPTPN1PPARGPPARD | |
| Glycolic Acid SCHEMBL432568 | 0.94 | FAAH (0.52) | FAAHTERTPTPN1PPARGPPARD | |
| Acetic Acid SCHEMBL6713983 | 0.93 | FAAH (0.54) | FAAHTERTMAPTBLMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080113892-A1 | Antimicrobial wash formulations including amidoamine-based cationic surfactants | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2008-05-15 | — | — | US | claimed |
| US-11447640-B2 | Encapsulated materials with improved properties | SUN CHEMICAL CORPORATION (US) | 2022-09-20 | — | — | US | disclosed |
| EP-3500601-B1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORP (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20210214561-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORPORATION (US) | 2021-07-15 | — | — | US | disclosed |
| EP-3500601-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | Sun Chemical Corporation (US) | 2019-06-26 | — | — | EP | disclosed |
| WO-2018035325-A1 | ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES | SUN CHEMICAL CORPORATION (US) | 2018-02-22 | — | — | WO | disclosed |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| US-7517842-B2 | Antimicrobial wash formulations including amidoamine-based cationic surfactants | GOJO INDUSTRIES, INC. (US) | 2009-04-14 | — | — | US | disclosed |
| WO-2008107347-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
| US-20060110379-A1 | Linkage of agents using microparticles | PERICOR SCIENCE, INC. (US) | 2006-05-25 | — | — | US | disclosed |
| US-20060104966-A1 | Transglutaminase linkage of agents to tissue | PERICOR SCIENCE, INC. (US) | 2006-05-18 | — | — | US | disclosed |
| US-6958148-B1 | Linkage of agents to body tissue using microparticles and transglutaminase | PERICOR SCIENCE, INC. (US) | 2005-10-25 | — | — | US | disclosed |
| US-6919076-B1 | Conjugates of agents and transglutaminase substrate linking molecules | PERICOR SCIENCE, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | FAAH 243/4885TERT 3271/4885PTPN1 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.